NCT05345444 2026-03-25
RTIRE
Weill Medical College of Cornell University
Phase NA Active not recruiting
Clinical Trials
10 trialsNCT04526730 2026-02-20
Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT06378047 2026-02-09
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT07328243 2026-01-09
IRE-TCLN
First Affiliated Hospital of Zhejiang University
Phase NA Recruiting
NCT07306273 2025-12-29
IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy
Ruijin Hospital
Phase 2 Recruiting
NCT06451445 2025-12-11
WIRED
University Health Network, Toronto
Phase NA Recruiting
NCT03484299 2025-10-29
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
University of Louisville
Phase 1 Recruiting
NCT06205849 2025-07-25
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
University of California, San Diego
Phase 1 Recruiting
NCT05555342 2025-05-14
A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm
University of California, Irvine
Phase EARLY_PHASE1 Completed
NCT04276857 2025-05-13
SMART
University of Saskatchewan
Phase NA Recruiting